DermBiont’s mission is to become the world’s leading precision dermatology company developing targeted topical therapeutics that treat, cure, and prevent diseases. The company aims to impact the root cause of skin diseases with biotherapeutics that repair an imbalance of the microbiome as well as through the development of targeted small molecule therapeutics with well-defined mechanisms of action. DermBiont’s biotherapeutics discovery team leverages computational biology and a proprietary bioinformatics platform to identify clinically meaningful dysbiosis related to common skin diseases and mines a curated library of microbes to build a pipeline of products to treat identified dysbiosis across indications.
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $71.2M
Founded date: 2017
Investors 6
| Date | Name | Website |
| - | Civilizati... | civilizati... |
| - | Joyance Pa... | joyancepar... |
| - | Start Capi... | start-capi... |
| - | Olive Tree... | olivetreec... |
| - | SymBiosis | symbiosis.... |
| - | Alchimia I... | alchimiain... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 24.10.2023 | Series B | $35.2M | - | finsmes.co... |
| 21.12.2021 | - | $28M | - | finsmes.co... |
| 18.06.2019 | Series A | $8M | - | finsmes.co... |
Mentions in press and media 14
| Date | Title | Description | Source |
| 24.10.2023 | DermBiont Closes $35.2M in Series B Funding | DermBiont, a Boston, MA-based clinical-stage biotechnology company, raised $35.2M in Series B fundin... | finsmes.co... |
| 02.10.2022 | The Motivation Behind our Microbiome Focus | Photo by CDC on Unsplash Scientific exploration of the microbiome represents the opening of one of ... | joyancepar... |
| 07.01.2022 | StartUPDATES: New developments from healthcare startups | DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, recently announce... | medcitynew... |
| 24.12.2021 | StartUPDATES: New developments for healthcare startups | DermBiont, a clinical stage biotechnology company developing targeted topical therapeutics that addr... | medcitynew... |
| 21.12.2021 | DermBiont Raises $28 Million in Series A2 Funding; Acquires ... | DermBiont, a Boston, MA-based clinical-stage biotechnology company developing targeted topical thera... | finsmes.co... |
| 08.01.2021 | DermBiont Announces Positive Results in Phase 2a Clinical Tr... | “We learn more about the microbiome and how to make live bacterium into drug products with each clin... | prweb.com/... |
| 08.01.2021 | DermBiont Announces Positive Results from Phase 2b Clinical ... | “DermBiont was founded to lead the field of evidence-based dermatology therapeutics that treat disea... | prweb.com/... |
| 01.10.2020 | Trusting Your Gut: How Our Portfolio Companies are Taking Ad... | Last month marked an important step for microbiome science: Cambridge, MA-based biotechnology compan... | socialstar... |
| 18.06.2019 | DermBiont Raises $8M in Series A Funding | DermBiont, a Boston, MA-based clinical stage therapeutics company dedicated to the discovery and dev... | finsmes.co... |
| 02.05.2019 | Press Release: Joyance Partners Announces European Expansion | London, UK - May 02, 2019 -- Joyance Partners, a venture capital partnership that invests in early-s... | socialstar... |
Show more